Gaetan Michel 4
4 · VOLITIONRX LTD · Filed Dec 21, 2018
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Gaetan Michel
Other
Transactions
- Disposition to Issuer
Option (Right to Buy)
2018-12-20−2,500→ 0 totalExercise: $3.00From: 2016-02-18Exp: 2020-02-18→ Common Stock (2,500 underlying) - Award
Option (Right to Buy)
2018-12-20+2,500→ 2,500 totalExercise: $3.00From: 2016-02-18Exp: 2020-08-18→ Common Stock (2,500 underlying) - Award
Option (Right to Buy)
2018-12-20+2,000→ 2,000 totalExercise: $4.00From: 2016-01-23Exp: 2021-07-23→ Common Stock (2,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2018-12-20−2,500→ 0 totalExercise: $2.50From: 2015-02-18Exp: 2019-02-18→ Common Stock (2,500 underlying) - Award
Option (Right to Buy)
2018-12-20+2,500→ 2,500 totalExercise: $2.50From: 2015-02-18Exp: 2020-08-18→ Common Stock (2,500 underlying) - Disposition to Issuer
Option (Right to Buy)
2018-12-20−2,000→ 0 totalExercise: $4.00From: 2016-01-23Exp: 2020-01-23→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020.
- [F2]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021.